Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-09

Clinical Trial Update: Effects of the Addition of Metyrapone to Antidepressant Therapy in Depression With Dexamethasone Suppression Test Non-suppression. [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating the addition of metyrapone to antidepressant therapy in depression with dexamethasone suppression test non-suppression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metyrapone (Metyrapone)

Snippet

Sponsor: Centre Hospitalier Rouffach | Conditions: Depressive Disorder, Hormone Disturbance | Phase 4 | Status: UNKNOWN